R42 Group

What is R42 Group?

R42 Group is an investment firm that specializes in budding industries with a focus on BioTech, FinTech and Financial Services, A.I. and Big Data, and DeepTech sectors. They aim to seed innovation by supporting startups at various funding stages, including Pre-Seed, Seed, Series A, and Series B investments.

The group is recognized for its contribution through both financial investment and strategic guidance, aligning with visionary entrepreneurs who strive to transform and advance these cutting-edge sectors. With a minimum investment of $100,000, a maximum of $10,000,000, and a 'sweet spot' investment typical around $1,000,000, R42 Group positions itself as a catalyst for growth and advancement within these highly specialized and technologically-driven fields.

Beyond the mere provision of capital, R42 Group extends its impact through the R42 Institute and the R42 AI and Longevity Club, platforms that nurture continuous learning and exchange within their focal industries.

The fund's uniqueness is further highlighted by the leadership of Dr. Ronjon Nag, a celebrated innovator and entrepreneur with an impressive background in genetics at the Stanford School of Medicine, and an extensive track record of pioneering work in AI and mobile technologies.

His achievements, honored by distinguished awards, and the precedent set by building and selling companies to tech giants such as Apple, BlackBerry, and Motorola, underline the fund's commitment to excellence and innovation in the dynamic intersection of AI and biology.